PRPL plunges 21% on weak sales outlook, down 29% YTD. Is it a buy?
Lilly's stock dips 19% YTD; Foundayo launch data awaited amid strong global demand for obesity drugs.
HYSA rates hit 4.1% APY, but Fed cuts loom. Secure, low-risk savings vs. market returns.
CVLT surges 10.7% on strong Q1 earnings, but full-year outlook is cautious. High ARR growth.
China halts new AV licenses after Baidu robotaxis stall. Baidu, Pony AI, WeRide shares drop amid safety review.
Crude premiums ease from record highs as refiners cut runs; demand destruction bites.
Centene (CNC) jumps 14.6% on strong earnings, raising guidance. Still below 52-week high.
Sponsored
Must Read